It Is Too Early for Pharma Investors to Cheer Opioid Verdict

Hold the celebration: The opioid litigation cloud hanging over drug stocks won’t clear up soon.

An Oklahoma judge ruled Monday that Johnson & Johnson is liable for fueling the opioid crisis and must pay $572 million. At first glance, that seems like a win for shareholders. The state’s attorneys had asked for as much as $17 billion in damages. Purdue Pharma and Teva Pharmaceutical Industries, which opted to settle Oklahoma’s claims instead of going to trial, paid $270 million and $85 million to resolve their cases, respectively.


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!